Pretreatment Lymphocyte Monocyte Ratio on Outcome HCC Patients
NCT03869151 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2019-04-02
Summary
To assess the prognostic role of pretreatment LMR in hepatocellular carcinoma(HCC).
Conditions
Interventions
- DIAGNOSTIC_TEST
-
CBC
lymphocyte and monocyte count
Sponsors & Collaborators
-
Amany Aboalenen Amin
lead OTHER
Principal Investigators
-
taha mahran, MD · Assiut University
-
ola abdelfatah, MD · Assiut University
-
aml ebraheem, MD · Assiut University
-
amany amin, master · Assiut University
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-05
- Primary Completion
- 2020-03-05
- Completion
- 2020-03-31
More Related Trials
-
Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test
NCT03493763 ·Status: UNKNOWN
-
Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis
NCT02794805 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure
NCT04310787 ·Status: RECRUITING
-
OBT Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI
NCT02415283 ·Status: UNKNOWN
-
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
NCT06537193 ·Status: RECRUITING ·Phase: NA
-
Liquid Biopsy-based Monitoring System for Relapse of HCC After Liver Transplantation: A Multi-center and Prospective Study
NCT03708705 ·Status: UNKNOWN
-
Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma
NCT04892810 ·Status: UNKNOWN
-
Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease
NCT01350167 ·Status: UNKNOWN ·Phase: NA
-
By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation
NCT03880721 ·Status: UNKNOWN
-
Study of microRNAs as a Diagnostic Tool for HCV-related Hepatocellular Carcinoma
NCT03429530 ·Status: UNKNOWN
-
Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation?
NCT06777017 ·Status: RECRUITING
-
Role of Abbreviated MRI in Follow-up of Hepatocellular Carcinoma .
NCT06168357 ·Status: NOT_YET_RECRUITING
-
Non-contrast Abbreviated MRI for Secondary Surveillance of HCC
NCT05690451 ·Status: COMPLETED
-
Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy
NCT01281683 ·Status: UNKNOWN
-
Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE
NCT03731910 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
NCT01871545 ·Status: COMPLETED ·Phase: NA
-
Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma
NCT01390194 ·Status: COMPLETED
-
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment
NCT01492127 ·Status: UNKNOWN ·Phase: NA
-
Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA)
NCT01447667 ·Status: COMPLETED ·Phase: NA
-
Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation
NCT01519219 ·Status: COMPLETED
-
Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)
NCT00866957 ·Status: COMPLETED
-
Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA
NCT05375370 ·Status: RECRUITING ·Phase: NA
-
Variations of Portal Flow During the Respiratory Cycle in Healthy Volunteers
NCT04782531 ·Status: COMPLETED ·Phase: NA
-
A Head-to-head Comparison of MRI, CT, 18F-FDGal and 18F-choline in Patients With Hepatocellular Carcinoma
NCT05359939 ·Status: RECRUITING ·Phase: NA
-
Characteristics and Treatment Outcome of Liver Abscesses: An Observational Study
NCT06852235 ·Status: NOT_YET_RECRUITING